Vitamin D3

Generic Name
Vitamin D3
Brand Names
Adrovance, Animi-3 With Vitamin D, Citranatal B-calm Kit, Citranatal Harmony, Fosamax Plus D, Fosavance, Infuvite, Infuvite Pediatric, Mvc-fluoride, Natafort, Pregvit, Vidextra
Drug Type
Small Molecule
Chemical Formula
C27H44O
CAS Number
67-97-0
Unique Ingredient Identifier
1C6V77QF41
Background

Vitamin D, in general, is a secosteroid generated in the skin when 7-dehydrocholesterol located there interacts with ultraviolet irradiation - like that commonly found in sunlight . Both the endogenous form of vitamin D (that results from 7-dehydrocholesterol transformation), vitamin D3 (cholecalciferol), and the plant-derived form, vitamin D2 (ergocalciferol), are considered the main forms of vitamin d and are found in various types of food for daily intake . Structurally, ergocalciferol differs from cholecalciferol in that it possesses a double bond between C22 and C23 and has an additional methyl group at C24 . Finally, ergocalciferol is pharmacologically less potent than cholecalciferol, which makes vitamin D3 the preferred agent for medical use .

Appropriate levels of vitamin D must be upheld in the body in order to maintain calcium and phosphorus levels in a healthy physiologic range to sustain a variety of metabolic functions, transcription regulation, and bone metabolism . However, studies are also ongoing to determine whether or not cholecalciferol may also play certain roles in cancer, autoimmune disorders, cardiovascular disease, and other medical conditions that may be associated with vitamin D deficiency .

Indication

Cholecalciferol use is indicated for the treatment of specific medical conditions like refractory rickets (or vitamin D resistant rickets), hypoparathyroidism, and familial hypophosphatemia .

Concurrently, as one of the most commonly utilized forms of vitamin D, cholecalciferol is also very frequently used as a supplement in individuals to maintain sufficient vitamin d levels in the body or to treat vitamin D deficiency, as well as various medical conditions that can be associated directly or indirectly with vitamin d insufficiency like osteoporosis and chronic kidney disease, among others .

Associated Conditions
Bone Fractures, Calcium and Vitamin D Deficiencies, Deficiency of Vitamin D3, Deficiency, Vitamin A, Deficiency, Vitamin D, Hip Fracture, Hypoparathyroidism, Hypophosphatemia, Familial, Menopause, Osteomalacia, Osteoporosis, Postmenopausal Osteoporosis, Vertebral Fractures, Vitamin D Resistant Rickets, Vitamin Deficiency, Severe Bone Resorption, Spine fracture
Associated Therapies
Calcium supplementation, Nutritional supplementation, Vitamin D Supplementation, Vitamin supplementation

Cholecalciferol on Hemodialysis Patients

First Posted Date
2018-07-26
Last Posted Date
2019-01-09
Lead Sponsor
Ain Shams University
Target Recruit Count
60
Registration Number
NCT03602430
Locations
🇪🇬

Ain Shams University Hospital, Cairo, Egypt

Repeated-dose Safety, Efficacy, Pharmacokinetic and Pharmacodynamic of CTAP101, Immediate-release Calcifediol, High-dose Cholecalciferol, and Paricalcitol Plus Low-dose Cholecalciferol in Patients With Secondary Hyperparathyroidism, Chronic Kidney Disease 3-4 and Vitamin D Insufficiency

First Posted Date
2018-07-17
Last Posted Date
2022-12-09
Lead Sponsor
OPKO Health, Inc.
Target Recruit Count
69
Registration Number
NCT03588884
Locations
🇺🇸

Research by Design, LLC, Chicago, Illinois, United States

🇺🇸

National Institute of Clinical Research, Inc., Garden Grove, California, United States

🇺🇸

Spaulding Clinical Research, West Bend, Wisconsin, United States

Association Between Vitamin D and the Development of Uterine Fibroids

First Posted Date
2018-07-12
Last Posted Date
2018-09-05
Lead Sponsor
Second Affiliated Hospital of Wenzhou Medical University
Target Recruit Count
360
Registration Number
NCT03584529
Locations
🇨🇳

The Second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Vitamin D Supplementation to Prevent Vitamin D Deficiency for Children With Epilepsy

Phase 3
Completed
Conditions
Interventions
First Posted Date
2018-05-25
Last Posted Date
2021-09-13
Lead Sponsor
King Saud University
Target Recruit Count
116
Registration Number
NCT03536845
Locations
🇸🇦

Reem ALKhalifah, Riyadh, Saudi Arabia

Changes in Serum Vitamin D Level After Different Loading Doses of Cholecalciferol

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2018-04-20
Last Posted Date
2018-04-20
Lead Sponsor
Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
Target Recruit Count
105
Registration Number
NCT03504280

Vitamine D in Drug Resistant Epilepsy

First Posted Date
2018-03-23
Last Posted Date
2024-07-12
Lead Sponsor
Centre Hospitalier St Anne
Target Recruit Count
88
Registration Number
NCT03475225
Locations
🇫🇷

Centre Hospitalier Sainte Anne, Paris, France

🇫🇷

Hôpital Kremlin Bicetre, Le Kremlin-Bicêtre, France

Pilot Study of OMEGA-3 and Vitamin D in High-Dose in Type I Diabetic Patients

First Posted Date
2018-01-23
Last Posted Date
2024-07-24
Lead Sponsor
Rodolfo Alejandro
Target Recruit Count
25
Registration Number
NCT03406897
Locations
🇺🇸

Diabetes Research Institute, University of Miami Miller School of Medicine, Miami, Florida, United States

XELOX/mFOLFOX Plus Vitamin D3 vs. XELOX/mFOLFOX as Firstline Chemotherapy in mCRC

Phase 3
Conditions
Interventions
First Posted Date
2018-01-03
Last Posted Date
2018-01-03
Lead Sponsor
Tianjin Medical University Cancer Institute and Hospital
Target Recruit Count
750
Registration Number
NCT03389659

Impact of Vitamin D Supplementation in Patients With Multiple Sclerosis

First Posted Date
2017-12-28
Last Posted Date
2019-03-20
Lead Sponsor
University Medical Centre Maribor
Target Recruit Count
89
Registration Number
NCT03385356
Locations
🇸🇮

University Medical Centre Maribor, Maribor, Slovenia

Metformin, Vitamin D, and Depression in Polycystic Ovary Syndrome (PCOS) Trial

First Posted Date
2017-12-20
Last Posted Date
2021-02-09
Lead Sponsor
University of California, San Francisco
Target Recruit Count
5
Registration Number
NCT03380091
Locations
🇺🇸

UCSF Center for Reproductive Health, San Francisco, California, United States

© Copyright 2024. All Rights Reserved by MedPath